Title 21

PART 524

Part 524 - Ophthalmic And Topical Dosage Form New Animal Drugs

PART 524 - OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS Authority:21 U.S.C. 360b. Source:40 FR 13873, Mar. 27, 1975, unless otherwise noted.

21:6.0.1.1.13.0.1SUBJGRP 1
   Fluocinolone Topical and Otic Dosage Forms
21:6.0.1.1.13.0.1.1SECTION 524.86
   524.86 Amitraz.
21:6.0.1.1.13.0.1.2SECTION 524.154
   524.154 Bacitracin, neomycin, and polymyxin B ophthalmic ointment.
21:6.0.1.1.13.0.1.3SECTION 524.155
   524.155 Bacitracin, neomycin, polymyxin B, and hydrocortisone ophthalmic ointment.
21:6.0.1.1.13.0.1.4SECTION 524.390
   524.390 Chloramphenicol ophthalmic ointment.
21:6.0.1.1.13.0.1.5SECTION 524.402
   524.402 Chlorhexidine.
21:6.0.1.1.13.0.1.6SECTION 524.450
   524.450 Clotrimazole.
21:6.0.1.1.13.0.1.7SECTION 524.463
   524.463 Copper naphthenate.
21:6.0.1.1.13.0.1.8SECTION 524.575
   524.575 Cyclosporine ophthalmic ointment.
21:6.0.1.1.13.0.1.9SECTION 524.590
   524.590 Diclofenac.
21:6.0.1.1.13.0.1.10SECTION 524.660
   524.660 Dimethyl sulfoxide.
21:6.0.1.1.13.0.1.11SECTION 524.770
   524.770 Doramectin.
21:6.0.1.1.13.0.1.12SECTION 524.775
   524.775 Emodepside and praziquantel.
21:6.0.1.1.13.0.1.13SECTION 524.802
   524.802 Enrofloxacin and silver sulfadiazine otic emulsion.
21:6.0.1.1.13.0.1.14SECTION 524.814
   524.814 Eprinomectin.
21:6.0.1.1.13.0.1.15SECTION 524.815
   524.815 Eprinomectin and praziquantel.
21:6.0.1.1.13.0.1.16SECTION 524.900
   524.900 Famphur.
21:6.0.1.1.13.0.1.17SECTION 524.920
   524.920 Fenthion.
21:6.0.1.1.13.0.1.18SECTION 524.955
   524.955 Florfenicol, terbinafine, and betamethasone acetate otic gel.
21:6.0.1.1.13.0.1.19SECTION 524.957
   524.957 Florfenicol, terbinafine, and mometasone otic solution.
21:6.0.1.1.13.0.1.20SECTION 524.960
   524.960 Flumethasone, neomycin, and polymyxin B ophthalmic solution.
21:6.0.1.1.13.0.1.21SECTION 524.970
   524.970 Flunixin.
21:6.0.1.1.13.0.1.22SECTION 524.981
   524.981 [Reserved]
21:6.0.1.1.13.0.1.23SECTION 524.981a
   524.981a Fluocinolone cream.
21:6.0.1.1.13.0.1.24SECTION 524.981b
   524.981b Fluocinolone solution.
21:6.0.1.1.13.0.1.25SECTION 524.981c
   524.981c Fluocinolone and neomycin cream.
21:6.0.1.1.13.0.1.26SECTION 524.981d
   524.981d Fluocinolone and dimethyl sulfoxide solution.
21:6.0.1.1.13.0.1.27SECTION 524.981e
   524.981e Fluocinolone and dimethyl sulfoxide otic solution.
21:6.0.1.1.13.0.1.28SECTION 524.998
   524.998 Fluralaner.
21:6.0.1.1.13.0.1.29SECTION 524.1001
   524.1001 Furalaner and moxidectin.
21:6.0.1.1.13.0.1.30SECTION 524.1005
   524.1005 Furazolidone powder.
21:6.0.1.1.13.0.1.31SECTION 524.1044
   524.1044 Gentamicin ophthalmic and topical dosage forms.
21:6.0.1.1.13.0.1.32SECTION 524.1044a
   524.1044a Gentamicin ophthalmic solution.
21:6.0.1.1.13.0.1.33SECTION 524.1044b
   524.1044b Gentamicin and betamethasone otic solution.
21:6.0.1.1.13.0.1.34SECTION 524.1044c
   524.1044c Gentamicin ophthalmic ointment.
21:6.0.1.1.13.0.1.35SECTION 524.1044d
   524.1044d Gentamicin and betamethasone ointment.
21:6.0.1.1.13.0.1.36SECTION 524.1044e
   524.1044e Gentamicin spray.
21:6.0.1.1.13.0.1.37SECTION 524.1044f
   524.1044f Gentamicin and betamethasone spray.
21:6.0.1.1.13.0.1.38SECTION 524.1044g
   524.1044g Gentamicin, betamethasone, and clotrimazole ointment.
21:6.0.1.1.13.0.1.39SECTION 524.1044h
   524.1044h Gentamicin, mometasone, and clotrimazole otic suspension.
21:6.0.1.1.13.0.1.40SECTION 524.1044i
   524.1044i Gentamicin and betamethasone ophthalmic solution.
21:6.0.1.1.13.0.1.41SECTION 524.1132
   524.1132 Hydrocortisone, miconazole, and gentamicin otic suspension.
21:6.0.1.1.13.0.1.42SECTION 524.1140
   524.1140 Imidacloprid and ivermectin.
21:6.0.1.1.13.0.1.43SECTION 524.1146
   524.1146 Imidacloprid and moxidectin.
21:6.0.1.1.13.0.1.44SECTION 524.1193
   524.1193 Ivermectin topical solution.
21:6.0.1.1.13.0.1.45SECTION 524.1195
   524.1195 Ivermectin otic suspension.
21:6.0.1.1.13.0.1.46SECTION 524.1200
   524.1200 Kanamycin ophthalmic and topical dosage forms.
21:6.0.1.1.13.0.1.47SECTION 524.1200a
   524.1200a Kanamycin ophthalmic ointment.
21:6.0.1.1.13.0.1.48SECTION 524.1200b
   524.1200b Kanamycin ophthalmic solution.
21:6.0.1.1.13.0.1.49SECTION 524.1204
   524.1204 Kanamycin, amphomycin, and hydrocortisone ointment.
21:6.0.1.1.13.0.1.50SECTION 524.1240
   524.1240 Levamisole.
21:6.0.1.1.13.0.1.51SECTION 524.1376
   524.1376 2-Mercaptobenzothiazole solution.
21:6.0.1.1.13.0.1.52SECTION 524.1443
   524.1443 Miconazole.
21:6.0.1.1.13.0.1.53SECTION 524.1445
   524.1445 Miconazole, polymixin B, and prednisolone suspension.
21:6.0.1.1.13.0.1.54SECTION 524.1446
   524.1446 Milbemycin otic solution.
21:6.0.1.1.13.0.1.55SECTION 524.1448
   524.1448 Mirtazapine transdermal ointment.
21:6.0.1.1.13.0.1.56SECTION 524.1450
   524.1450 Moxidectin.
21:6.0.1.1.13.0.1.57SECTION 524.1465
   524.1465 Mupirocin.
21:6.0.1.1.13.0.1.58SECTION 524.1484
   524.1484 Neomycin ophthalmic and topical dosage forms.
21:6.0.1.1.13.0.1.59SECTION 524.1484b
   524.1484b Neomycin, isoflupredone, and tetracaine powder.
21:6.0.1.1.13.0.1.60SECTION 524.1484c
   524.1484c Neomycin, isoflupredone, and tetracaine ointment.
21:6.0.1.1.13.0.1.61SECTION 524.1484d
   524.1484d Neomycin, hydrocortisone, and tetracaine otic ointment.
21:6.0.1.1.13.0.1.62SECTION 524.1484e
   524.1484e Neomycin and polymyxin B ophthalmic solution.
21:6.0.1.1.13.0.1.63SECTION 524.1484f
   524.1484f Neomycin, prednisolone, and tetracaine otic suspension.
21:6.0.1.1.13.0.1.64SECTION 524.1484g
   524.1484g Neomycin, thiabendazole, and dexamethasone solution.
21:6.0.1.1.13.0.1.65SECTION 524.1484h
   524.1484h Neomycin, penicillin, polymyxin B, and hydrocortisone suspension.
21:6.0.1.1.13.0.1.66SECTION 524.1484i
   524.1484i Neomycin and hydrocortisone ointment.
21:6.0.1.1.13.0.1.67SECTION 524.1484j
   524.1484j Neomycin and prednisolone ophthalmic ointment.
21:6.0.1.1.13.0.1.68SECTION 524.1484k
   524.1484k Neomycin and prednisolone suspension.
21:6.0.1.1.13.0.1.69SECTION 524.1580
   524.1580 Nitrofurazone topical dosage forms.
21:6.0.1.1.13.0.1.70SECTION 524.1580a
   524.1580a Nitrofurazone ointment.
21:6.0.1.1.13.0.1.71SECTION 524.1580b
   524.1580b Nitrofurazone soluble powder.
21:6.0.1.1.13.0.1.72SECTION 524.1580c
   524.1580c Nitrofurazone and butacaine ointment.
21:6.0.1.1.13.0.1.73SECTION 524.1600
   524.1600 Nystatin ophthalmic and topical dosage forms.
21:6.0.1.1.13.0.1.74SECTION 524.1600a
   524.1600a Nystatin, neomycin, thiostrepton, and triamcinolone ointment.
21:6.0.1.1.13.0.1.75SECTION 524.1600b
   524.1600b Nystatin, neomycin, thiostrepton, and triamcinolone ophthalmic ointment.
21:6.0.1.1.13.0.1.76SECTION 524.1610
   524.1610 Orbifloxacin, mometasone furoate monohydrate, and posaconazole suspension.
21:6.0.1.1.13.0.1.77SECTION 524.1662
   524.1662 Oxytetracycline ophthalmic and topical dosage forms.
21:6.0.1.1.13.0.1.78SECTION 524.1662a
   524.1662a Oxytetracycline and hydrocortisone spray.
21:6.0.1.1.13.0.1.79SECTION 524.1662b
   524.1662b Oxytetracycline and polymyxin B ophthalmic ointment.
21:6.0.1.1.13.0.1.80SECTION 524.1742
   524.1742 Phosmet emulsifiable liquid.
21:6.0.1.1.13.0.1.81SECTION 524.1982
   524.1982 Proparacaine ophthalmic solution.
21:6.0.1.1.13.0.1.82SECTION 524.2098
   524.2098 Selamectin.
21:6.0.1.1.13.0.1.83SECTION 524.2099
   524.2099 Selamectin and sarolaner.
21:6.0.1.1.13.0.1.84SECTION 524.2101
   524.2101 Selenium disulfide suspension.
21:6.0.1.1.13.0.1.85SECTION 524.2350
   524.2350 Tolnaftate cream.
21:6.0.1.1.13.0.1.86SECTION 524.2482
   524.2482 Triamcinolone spray.
21:6.0.1.1.13.0.1.87SECTION 524.2483
   524.2483 Triamcinolone cream.
21:6.0.1.1.13.0.1.88SECTION 524.2620
   524.2620 Liquid crystalline trypsin, Peru balsam, castor oil.